In December 2017, the Transnational Institute (TNI) and Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ), on behalf of the Federal Ministry of Economic Cooperation and Development of Germany (BMZ), in collaboration with the Thai Office of the Narcotics Control Board (ONCB) and the Mae Fah Luang Foundation under Royal Patronage (MFLF), jointly organised the 9th Asian Informal Drug Policy Dialogue (IDPD) in Chiang Rai, Thailand.
From 15 to 18 November 2018, the Transnational Institute (TNI) and Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH, on behalf of the German Federal Ministry for Economic Cooperation and Development (BMZ) jointly organised the 10th Asian Informal Drug Policy Dialogue (IDPD). It was organised in collaboration with the Central Committee for Drug Abuse Control (CCDAC) of Myanmar and held at Inle Lake, Southern Shan State, Myanmar.
Heino Stöver, Ingo Ilja Michels, Bernd Werse, Tim Pfeiffer-Gerschel
29 March 2019
While medical cannabis is well accepted in Germany and small-scale possession is officially decriminalized, many cities are struggling with high levels of street dealing. A number of cities are pushing for different kinds of public "experiments" in legal distribution that would allow them to better control cannabis in their jurisdictions. Produced as part of a the "New Approaches in Harm Reduction Policies and Practices" project, this Country Report seeks to understand the drivers of German cannabis policy today, and the possibilities for its future.
Around the world, millions of people depend on the cultivation of coca, opium poppy and cannabis for basic subsistence. The 1961 Convention introduced strict controls on the cultivation of these plants and banned centuries-old traditional medicinal, cultural and ceremonial uses. The 1988 Convention reinforced those provisions, obliging states to eradicate illicit cultivation and to impose criminal sanctions.
The eleventh Informal Drug Policy Dialogue took place in Athens. Topics amongst others were the national drug policy and drug situation in Greece, current affairs in Vienna, global cannabis policy developments and the upcoming UN General Assembly Special Session on Drugs in 2016.
Countries that embrace legal regulation find themselves in breach of international law. In this video, we explain a strategy to resolve those treaty tensions and to enable progressive and sustainable change at the global level.
The admission by UN's lead agency for drugs, the UNODC, that “the drug market is thriving” in its 2017 World Drug Report is an important one given that it is months away from 2019 – the target date by which governments committed to “significantly reduce or eliminate” the global drug market. At the recent annual gathering of the Commission on Narcotic Drugs (CND) in Vienna, this abysmal failure to claim any progress towards these ‘drug-free’ targets was the backdrop to the latest round of tense negotiations on global drug control.
In support of our long-term goals, which also indicate the type of work TNI does, an ambitious five-year programme was developed in 2014. Although 2018 only marks the mid-point in implementation, impressive progress is already apparent.
The eleventh Informal Drug Policy Dialogue took place in Athens, co-organised by TNI and Diogenes Association. The programme incuded five sessions: (1) an overview of the national Greek drug policy and the drug situation in Greece, developments in drug policy in Greece; (2) the current state of affairs in Vienna; preparations for the CND high-level review and negotiations of the joint Ministerial Statement;(3) global cannabis policy developments; (4) the control of New Psychoactive Substances (NPS) ; (5) the road towards the upcoming UN General Assembly Special Session on Drugs (UNGASS on drugs) in 2016 has been discussed.
John Walsh, Ann Fordham, Martin Jelsma, Hannah Hetzer
22 September 2018
The "Global Call to Action" document that the U.S. government is circulating—and heavily pressuring reluctant countries to sign—is explicitly “not open for negotiation.” Far from an effort at achieving mutual understanding and genuine consensus, it is an instance of heavy-handed U.S. “with us or against us” diplomacy.
David Bewley-Taylor, Tom Blickman, Martin Jelsma, John Walsh
03 April 2018
Ever since the introduction of Bill C-45, questions have been swirling concerning Canada’s position relative to the UN drug control conventions: conventions to which Canada is a party and that, crucially, prohibit the creation of regulated markets for the recreational use of cannabis.
Tom Blickman, Katie Sandwell, Dania Putri, Xabier Arana, Tom Decorte, Vibeke Asmussen Frank, Dirk J. Korf, Ingo Ilja Michels, Maj Nygaard-Christensen, Tim Pfeiffer-Gerschel, Heino Stöver, Bernd Werse, Frank Zobel
20 March 2019
In order to better understand the situation around, and possibilities for, local and regional cannabis regulation, a series of six country reports were developed. The country reports provide detailed information about the state of cannabis policy, and the possibilities for change, within each country. This Report summarises some of the key findings from the research and explores opportunities, obstacles, and strategies for cannabis regulation at the municipal and regional level.
How do we recover the emancipatory potential of technological change and bring it back under popular democratic control? As part of its Future Labs work, TNI is working with IT for Change to deepen our analysis and research on the impacts of rapid technological change in all of our areas of work. In 2021, TNI launched a series of essays in conjunction with ROAR magazine to stimulate debate and reflection.
In Myanmar’s Kachin State, a women’s drop-in centre has transformed into more than just a harm reduction facility. Leading up to International Women’s Day, we spoke with Thinzar Tun (AHRN Myanmar) about what makes this centre special.
John Walsh, Martin Jelsma, Tom Blickman, David Bewley-Taylor
19 March 2019
The World Health Organization’s (WHO) Expert Committee on Drug Dependence (ECDD or Expert Committee) released in January 2019 the outcomes of the first-ever critical review of cannabis, recommending a series of changes in the current scheduling of cannabis-related substances under the UN drug control conventions.